BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 26638171)

  • 1. Immunomonitoring in glioma immunotherapy: current status and future perspectives.
    Lamano JB; Ampie L; Choy W; Kesavabhotla K; DiDomenico JD; Oyon DE; Parsa AT; Bloch O
    J Neurooncol; 2016 Mar; 127(1):1-13. PubMed ID: 26638171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring immune responses after glioma vaccine immunotherapy.
    Jian B; Yang I; Parsa AT
    Neurosurg Clin N Am; 2010 Jan; 21(1):195-9. PubMed ID: 19944978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell- and peptide-based immunotherapeutic approaches for glioma.
    Yamanaka R
    Trends Mol Med; 2008 May; 14(5):228-35. PubMed ID: 18403264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide vaccine.
    Izumoto S
    Adv Exp Med Biol; 2012; 746():166-77. PubMed ID: 22639167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immunotherapy: a new approach to the treatment of malignant glioma.
    Yang L; Ng KY; Lillehei KO
    Cancer Control; 2003; 10(2):138-47. PubMed ID: 12712008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focused ultrasound-induced blood-brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study.
    Chen PY; Hsieh HY; Huang CY; Lin CY; Wei KC; Liu HL
    J Transl Med; 2015; 13():93. PubMed ID: 25784614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cellular immunotherapy for malignant glioma].
    Okamoto Y; Yamashita J
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():557-62. PubMed ID: 16201581
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunotherapy targeting glioma stem cells--insights and perspectives.
    Li Z; Lee JW; Mukherjee D; Ji J; Jeswani SP; Black KL; Yu JS
    Expert Opin Biol Ther; 2012 Feb; 12(2):165-78. PubMed ID: 22200324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Principles of immunotherapy.
    Liebelt BD; Finocchiaro G; Heimberger AB
    Handb Clin Neurol; 2016; 134():163-81. PubMed ID: 26948354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for human glioma: innovative approaches and recent results.
    Hussain SF; Heimberger AB
    Expert Rev Anticancer Ther; 2005 Oct; 5(5):777-90. PubMed ID: 16221048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of tumor antigen-specific T-cells isolated from the tumor microenvironment of sleeping beauty induced murine glioma models.
    Alghamri MS; Núñez FJ; Kamran N; Carney S; Altshuler D; Lowenstein PR; Castro MG
    Methods Enzymol; 2020; 631():91-106. PubMed ID: 31948569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioma antigen.
    Toda M
    Adv Exp Med Biol; 2012; 746():77-84. PubMed ID: 22639160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive immunotherapy of malignant glioma using tumor-sensitized T lymphocytes.
    Merchant RE; Baldwin NG; Rice CD; Bear HD
    Neurol Res; 1997 Apr; 19(2):145-52. PubMed ID: 9175143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response.
    Tsugawa T; Kuwashima N; Sato H; Fellows-Mayle WK; Dusak JE; Okada K; Papworth GD; Watkins SC; Gambotto A; Yoshida J; Pollack IF; Okada H
    Gene Ther; 2004 Nov; 11(21):1551-8. PubMed ID: 15343358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular immunity in the treatment of brain tumors.
    Wheeler CJ; Yu JS; Black KL
    Clin Neurosurg; 2004; 51():132-9. PubMed ID: 15571138
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetics and immunotherapy: using the genetic landscape of gliomas to inform management strategies.
    Wang JY; Bettegowda C
    J Neurooncol; 2015 Jul; 123(3):373-83. PubMed ID: 25697584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell-based immunotherapy for malignant gliomas.
    Akasaki Y; Black KL; Yu JS
    Expert Rev Neurother; 2005 Jul; 5(4):497-508. PubMed ID: 16026233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell vaccines.
    Yamanaka R; Kajiwara K
    Adv Exp Med Biol; 2012; 746():187-200. PubMed ID: 22639169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concepts of immunotherapy for glioma.
    Patel MA; Pardoll DM
    J Neurooncol; 2015 Jul; 123(3):323-30. PubMed ID: 26070552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunobiology and immunotherapeutic targeting of glioma stem cells.
    Madany M; Thomas TM; Edwards L; Yu JS
    Adv Exp Med Biol; 2015; 853():139-66. PubMed ID: 25895711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.